INMED PHARMACEUTICALS INC. Investment Income, Interest
INMED PHARMACEUTICALS INC. (INM) reported Investment Income, Interest of $244.97 thousand for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-09-09
- INMED PHARMACEUTICALS INC. investment income, interest for the quarter ending 2026-06-30 was $29.06K, a 43.78% decline year-over-year.
- INMED PHARMACEUTICALS INC. investment income, interest for the quarter ending 2026-03-31 was $47.77K, a 188.38% increase year-over-year.
- INMED PHARMACEUTICALS INC. investment income, interest for the quarter ending 2025-12-31 was $74.38K, a 143.58% increase year-over-year.
- INMED PHARMACEUTICALS INC. investment income, interest for the quarter ending 2025-09-30 was $93.77K, a 64.23% increase year-over-year.
- INMED PHARMACEUTICALS INC. investment income, interest for fiscal 2023 was $492.44K, a 412.48% increase from fiscal 2022.
- INMED PHARMACEUTICALS INC. investment income, interest for fiscal 2022 was $96.09K, a 499.93% increase from fiscal 2021.
- INMED PHARMACEUTICALS INC. investment income, interest for fiscal 2021 was $16.02K, a 87.63% decline from fiscal 2020.
- INMED PHARMACEUTICALS INC. investment income, interest for fiscal 2020 was $129.53K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29.06K derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $76.83K derived: sum of 2 quarters · filed 2026-09-09 | $151.21K derived: sum of 3 quarters · filed 2026-09-09 | $244.97K S-4/A · filed 2026-09-09 | ||
| 2026-03-31 | $47.77K S-4 · filed 2026-07-02 | $122.15K derived: sum of 2 quarters · filed 2026-07-02 | $215.91K S-4 · filed 2026-07-02 | $267.60K derived: sum of 4 quarters · filed 2026-09-09 | ||
| 2025-12-31 | $74.38K 10-Q · filed 2026-02-11 | $168.14K 10-Q · filed 2026-02-11 | $219.83K derived: sum of 3 quarters · filed 2026-09-09 | $236.40K derived: sum of 4 quarters · filed 2026-09-09 | ||
| 2025-09-30 | $93.77K 10-Q · filed 2025-11-06 | $145.45K derived: sum of 2 quarters · filed 2026-09-09 | $162.02K derived: sum of 3 quarters · filed 2026-09-09 | $192.55K derived: sum of 4 quarters · filed 2026-09-09 | ||
| 2025-06-30 | $51.69K derived: S-4/A 12 month − S-4 9 month · filed 2026-09-09 | $68.25K derived: sum of 2 quarters · filed 2026-09-09 | $98.79K derived: sum of 3 quarters · filed 2026-09-09 | $155.88K S-4/A · filed 2026-09-09 | ||
| 2025-03-31 | $16.57K S-4 · filed 2026-07-02 | $47.10K derived: sum of 2 quarters · filed 2026-07-02 | $104.19K S-4 · filed 2026-07-02 | $207.84K derived: sum of 4 quarters · filed 2026-07-02 | ||
| 2024-12-31 | $30.54K 10-Q · filed 2026-02-11 | $87.63K 10-Q · filed 2026-02-11 | $191.27K derived: sum of 3 quarters · filed 2026-07-02 | $312.73K derived: sum of 4 quarters · filed 2026-07-02 | ||
| 2024-09-30 | $57.09K 10-Q · filed 2025-11-06 | $160.73K derived: sum of 2 quarters · filed 2026-07-02 | $282.19K derived: sum of 3 quarters · filed 2026-07-02 | $448.95K derived: sum of 4 quarters · filed 2026-07-02 | ||
| 2024-06-30 | $103.64K derived: S-4 12 month − 10-Q 9 month · filed 2026-07-02 | $225.10K derived: sum of 2 quarters · filed 2026-07-02 | $391.86K derived: sum of 3 quarters · filed 2026-07-02 | $527.90K S-4 · filed 2026-07-02 | ||
| 2024-03-31 | $121.46K 10-Q · filed 2025-05-12 | $288.22K derived: sum of 2 quarters · filed 2025-05-12 | $424.26K 10-Q · filed 2025-05-12 | $572.82K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $166.76K 10-Q · filed 2025-02-12 | $302.80K 10-Q · filed 2025-02-12 | $451.36K derived: sum of 3 quarters · filed 2025-02-12 | $606.86K derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-09-30 | $136.04K 10-Q · filed 2024-11-14 | $284.60K derived: sum of 2 quarters · filed 2024-11-14 | $440.10K derived: sum of 3 quarters · filed 2024-11-14 | $555.90K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $148.56K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $304.06K derived: sum of 2 quarters · filed 2024-09-30 | $419.85K derived: sum of 3 quarters · filed 2024-09-30 | $492.44K 10-K · filed 2024-09-30 | ||
| 2023-03-31 | $155.50K 10-Q · filed 2023-05-15 | $271.29K derived: sum of 2 quarters · filed 2024-02-13 | $343.88K 10-Q · filed 2023-05-15 | $377.58K derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-12-31 | $115.80K 10-Q · filed 2024-02-13 | $188.38K 10-Q · filed 2024-02-13 | $222.09K derived: sum of 3 quarters · filed 2024-02-13 | $253.05K derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-09-30 | $72.59K 10-Q · filed 2022-11-14 | $106.29K derived: sum of 2 quarters · filed 2022-11-14 | $137.25K derived: sum of 3 quarters · filed 2023-05-15 | $163.53K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2022-06-30 | $33.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-23 | $64.67K derived: sum of 2 quarters · filed 2023-05-15 | $90.94K derived: sum of 3 quarters · filed 2023-05-15 | $96.09K 10-K · filed 2022-09-23 | ||
| 2022-03-31 | $30.96K 10-Q · filed 2023-05-15 | $57.24K derived: sum of 2 quarters · filed 2023-05-15 | $62.39K 10-Q · filed 2023-05-15 | $67.21K derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $26.28K 10-Q · filed 2023-02-17 | $4.22K 10-Q · filed 2022-02-14 | $31.43K 10-Q · filed 2023-02-17 | $9.37K 10-Q · filed 2022-02-14 | $36.25K derived: sum of 3 quarters · filed 2023-02-17 | $40.05K derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-09-30 | $5.15K 10-Q · filed 2022-11-14 | $9.97K derived: sum of 2 quarters · filed 2022-11-14 | $13.77K derived: sum of 3 quarters · filed 2022-11-14 | $16.82K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $4.83K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-23 | $8.62K derived: sum of 2 quarters · filed 2022-09-23 | $11.67K derived: sum of 3 quarters · filed 2022-09-23 | $16.02K 10-K · filed 2022-09-23 | ||
| 2021-03-31 | $3.80K 10-Q · filed 2022-05-13 | $6.85K derived: sum of 2 quarters · filed 2022-05-13 | $11.19K 10-Q · filed 2022-05-13 | $15.49K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $3.05K 10-Q · filed 2022-02-14 | $7.39K 10-Q · filed 2022-02-14 | $11.69K derived: sum of 3 quarters · filed 2022-02-14 | $38.02K derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-09-30 | $4.34K 10-Q · filed 2021-11-10 | $8.64K derived: sum of 2 quarters · filed 2021-11-10 | $34.97K derived: sum of 3 quarters · filed 2021-11-10 | $75.47K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $4.29K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | $30.63K derived: sum of 2 quarters · filed 2021-09-24 | $71.12K derived: sum of 3 quarters · filed 2021-09-24 | $129.53K 10-K · filed 2021-09-24 | ||
| 2020-03-31 | $26.33K 10-Q · filed 2021-05-13 | $66.83K derived: sum of 2 quarters · filed 2021-05-13 | $125.23K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $40.49K 10-Q · filed 2021-02-11 | $98.90K 10-Q · filed 2021-02-11 | ||||
| 2019-09-30 | $58.41K 10-Q · filed 2020-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |